Elena Ridloff, CFA

Elena Ridloff has over 20 years of experience in finance and the life sciences industry.  She is currently the Chief Financial Officer of a stealth biotechnology company.  Previously she was Executive Vice President and Chief Financial Officer for ACADIA Pharmaceuticals where she was responsible for leading corporate finance, accounting, investor relations and corporate affairs functions.  Prior to joining Acadia, Ms. Ridloff was Vice President, Investor Relations at Alexion Pharmaceuticals and served as a member of the Operating Committee. Additionally, Ms. Ridloff was Chief Executive Officer and Managing Member of BIOVISIO, an independent consulting firm serving the life sciences industry. She was also a Managing Director at Maverick Capital, a hedge fund based in New York, and was responsible for investments in the biotechnology, pharmaceutical, medical device, and life science sectors. She currently serves on the Board of Directors of Kronos Bio, Inc.

Ms. Ridloff received her BA in History and Sociology of Science from the University of Pennsylvania. She is also a CFA© charterholder.